Evolution of Share Prices

The BOIRON share price closed the 2015 period at €74.50, up 7.2% from its level of €69.52 in January 2, 2015 (opening price).

The BOIRON share price peaked at €112.80 during the April 10, 2015 trading session and fell to a low of €66.01 during the January 8, 2015 trading session.

Over the year as a whole, 2,006,331 shares were traded, with an average of 7,837 shares per trading session.

When compared to 2014, the number of shares traded in 2015 decreased 30.1% and represented 10.3% of the Company's share capital.

Share details

Share listed on the NYSE of EURONEXT Paris and included in the CAC Small, ENT PEA-PME 150, Euronext FAS IAS, CAC Pharma & Bio, CAC Health Care, CAC PME, CAC Mid and Small, CAC All Shares, CAC All-Tradable and I.A.S.indices.

ISIN Code : FR0000061129 (BOI)

Reuters : BOIR.PA

Bloomberg : BOI FP

Establishment in charge of share registrations : BNP PARIBAS SECURITIES SERVICES

Animation Contract : NATIXIS

Share Price History

June 1987 Entry of BOIRON shares to the Second Marché of the Lyon Stock Exchange.
June 1992 Issue of a convertible bond issue for 150.41 MFRF.
November 1994 Admission of BOIRON shares to the SBF 250 index.
June 1996 Advance reimbursement of the convertible bond issue.
May 1999 Launch of a share buy-back program.
December 1999 Cancellation of 111,739 shares acquired by the company within the framework of a share buy-back program. Reduction of the share capital from FRF 127,283,500 to FRF 124,490,025.
November 2000 End of the share buy-back program launched in May 1999.
December 2000 Cancellation of 311,601 shares acquired by the company within yhe framework of a share buy-back program. Reduction of the share capital from FRF 124,490,025 to FRF 116,700,000.
May 2001 Launch of a new share buy-back program.
December 2001 Conversion of the share capital to Euros on January 1, 2002. Fixing of the face value at 4 euros. Capital increase through the incorporation of reserves in the amount of FRF 5,780,291 from FRF116,700,000 to FRF122,480,291, i.e. €18,672,000 divided into 4,688,000 shares of 4 Euros each.
May 2003 On July1, 2003 division of the face value of the share by 4 Euros.The share capital has been set at €18,672,000 and dividend into 18,672,000 shares of 1 Euro each.
June 2005 Merger with LABORATOIRES DOLISOS and resulting increase in capital of €3,334,286 through the creation of 3,334,286 new shares. The share capital amounts to €22,006,286 divided into 22,006,286 shares of 1 Euro each.
May 2006 Launch of a new share buy-back program.
May 2007 Launch of a new share buy-back program.
December 2007 As from January 1,2008 cancellation of 58,720 shares acquired by the company within the framework of the share buy-back program. reduction of the share capital from €22,006,286 to €21,947,566.
May 2008 Launch of a new share buy-back program.
December 2008 As from January 1, 2009, cancellation of 213,038 shares acquired by the comapny within the framework of the share buy-back program. Reduction of the share capital from €21,947,566 to €21,734,528.
May 2009 Launch of a new share buy-back program.
December 2009 As from January 1,2010, cancellation of 251,972 shares acuired by the company within the framework of the share buy-back program. reduction of the share capital from €21,734,528 to €21,482,556.
May 2010 Launch of a new share buy-back program.
May 2011 Launch of a new share buy-back program.
May 2012 Launch of a new share buy-back program.
December 2012 As from January 1, 2013, cancellation of 2,040,843 shares acquired by the company within the framework of the share buy-back program. Reduction of the share capital from €21,482,556 to €19,441,713.
May 2013 Launch of a new share buy-back program.
May 2014 Launch of a new share buy-back program.
May 2015 Launch of a new share buy-back program.